Leading Global Provider of Preimplantation Genetic Testing Services Moves to Plymouth, Michigan

PLYMOUTH, Mich., Dec. 23, 2013 /PRNewswire-USNewswire/ -- After nearly a decade in the city of Detroit, Genesis Genetics has moved its corporate headquarters to Plymouth, Michigan. Tony Gordon Ph.D., Genesis Genetics Managing Director, leads the team of scientists, genetic counselors and case coordinators. In the United States, Genesis Genetics focuses its science on two important fertility technologies: Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD).

(http://photos.prnewswire.com/prnh/20131223/DC37739)

The move to Plymouth was strategically planned. In addition to needing more laboratory space for the rapidly growing company, the 13-year-old firm also wanted to move to a location that would be inspirational to its team. Says Gordon, "Our mission is to help couples build healthy families. Plymouth is a quintessential American family town with concerts in the park, a multitude of family festivals, events and parades, and a bustling downtown replete with couples with young families. It just made sense." He is quick to add that the location is also simpler commute to Detroit Metro Airport as the firm's work depends on timely courier deliveries.

The city of Plymouth is excited to have a growing bio-tech company downtown on Main Street. Mayor Pro-tem, Ed Hingleberg said he was thrilled to see the building at 705 South Main now completely full and, "We love that our neighbor to the West, Ann Arbor, has become a mecca for these types of companies, but we are equally thrilled that global companies like Genesis Genetics are thinking about our city and all its offerings."

In addition to the headquarters in Plymouth, Michigan, Genesis Genetics has laboratories in Arizona, Argentina, Brazil, Jordan, South Africa, Taiwan and the United Kingdom. Gordon added, "The quantity and location of our labs are particularly significant. It gives us the opportunity to make our tests and customer service available to a global audience."

PGD is a laboratory procedure that is used in conjunction with in vitro fertilization (IVF) to help detect certain single-gene diseases. Genesis Genetics was the first to perform this testing and is known globally for the ability to test for some of the rarest genetic conditions. Genesis Genetics works with IVF clinics to offer PGD as an option to couples who are at risk of having a child with an inherited disorder.

With PGS, an embryo can be transferred in an IVF cycle after being tested for chromosomal abnormalities. Genesis Genetics' unique service gives potential parents the ability to quickly decide to undergo the test and select embryos with normal numbers of chromosomes.  Timely reporting of results is critical and key to Genesis Genetics service. "Faster results eliminate what could be a long and stressful waiting period," Gordon said. "Moving to Plymouth has aided all our processes."        

About Genesis Genetics
Genesis Genetics, founded by world-renowned scientists largely responsible for discovering preimplantation genetic diagnosis (PGD) as a clinical practice, is the leading global provider of PGD and provides expert laboratory services for some of the most respected in vitro fertilization (IVF) centers across the country and throughout the world. Genesis Genetics has laboratories in Argentina, Brazil, Jordon, South Africa, Taiwan, United Kingdom, and the United States. For more information visit www.genesisgenetics.org.

Contact: Dorothy Twinney
[email protected]
Phone: +1 313-259-5507
Fax: +1 313-259-3474

SOURCE Genesis Genetics